SCHEMBL23095433

SCHEMBL23095433

C/C=C1C(=C/C)\C(=O)c2ccccc2\1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.54
ALDH1A1 P00352 7/20 0.54
HTT P42858 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
HIF1A Q16665 2/20 0.54
KMT2A Q03164 7/20 0.50
MEN1 O00255 4/20 0.50
CDC25B P30305 3/20 0.50
POLB P06746 4/20 0.48
RAB9A P51151 3/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 2/20 0.48
BLM P54132 2/20 0.48
THRB P10828 2/20 0.48
MAPK1 P28482 2/20 0.48
RECQL P46063 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
NPC1 O15118 2/20 0.48
APAF1 O14727 2/20 0.48
TDP2 O95551 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14431153 0.95 MAPT (0.58) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL19336216 0.93 MAPT (0.52) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL1104624 0.90 MAPT (0.58) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL13063848 0.84 MAPT (0.44) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL19336218 0.81 MAPT (0.46) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL16603083 0.81 MAPT (0.46) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL21241093 0.81 MAPT (0.46) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL23095418 0.80 MAPT (0.48) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL23730605 0.80 S100A4 (0.56) MAPTALDH1A1HTTSMN1; SMN2HIF1A
SCHEMBL16065002 0.78 MAPT (0.43) MAPTALDH1A1HTTSMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10950806-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2021-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10950806-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same OR10J3, ORC3, ICOSLG MAPT 1219/4885ALDH1A1 699/4885HTT 3638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.